EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease

Andrey Tsoy iD, Bauyrzhan Umbayev iD, Aliya Kassenova iD, Bibifatima Kaupbayeva, Sholpan Askarova iD

International Journal of Molecular Sciences · 11.10.2024 · 25 (20) · 10964

DOI: 10.3390/ijms252010964 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.10.2024. Verfasst von Andrey Tsoy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Blood-Brain Barrier. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education and Science of the Republic of Kazakhstan, Nazarbayev University Collaborative Research Program Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although Alzheimer’s disease (AD) is traditionally viewed as a central nervous system disorder driven by the cerebral accumulation of toxic beta-amyloid (Aβ) peptide, new interpretations of the amyloid cascade hypothesis have led to the recognition of the dynamic equilibrium in which Aβ resides and the importance of peripheral Aβ production and degradation in maintaining healthy Aβ levels. Our review sheds light on the critical role of peripheral organs, particularly the liver, in the metabolism and clearance of circulating Aβ. We explore the mechanisms of Aβ transport across the blood–brain barrier (BBB) via transport proteins such as LRP1 and P-glycoprotein. We also examine how peripheral clearance mechanisms, including enzymatic degradation and phagocytic activity, impact Aβ homeostasis. Our review also discusses potential therapeutic strategies targeting peripheral Aβ clearance pathways. By enhancing these pathways, we propose a novel approach to reducing cerebral Aβ burden, potentially slowing AD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBlood-Brain BarrierHumansAnimalsLow Density Lipoprotein Receptor-Related Protein-1Liver

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-β peptideenzymatic degradationperipheral clearance

Substanzen

Amyloid beta-PeptidesLow Density Lipoprotein Receptor-Related Protein-1

Autor:innen und Institutionen

  • Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.
  • Faculty of Natural Sciences, Eurasian National University, Astana 010000, Kazakhstan.

ORCID-Profile: Andrey Tsoy, Bauyrzhan Umbayev, Aliya Kassenova, Sholpan Askarova

Förderung

  • Ministry of Education and Science of the Republic of Kazakhstan
  • Nazarbayev University Collaborative Research Program Grants

Zitieren

APA

Tsoy, A., Umbayev, B., Kassenova, A., Kaupbayeva, B., & Askarova, S. (2024). Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease. International Journal of Molecular Sciences, 25(20), 10964. https://doi.org/10.3390/ijms252010964

Vancouver

Tsoy A, Umbayev B, Kassenova A, Kaupbayeva B, Askarova S. Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease. International Journal of Molecular Sciences. 2024;25(20):10964. doi:10.3390/ijms252010964

BibTeX
@article{Tsoy2024,
  author = {Tsoy, Andrey and Umbayev, Bauyrzhan and Kassenova, Aliya and Kaupbayeva, Bibifatima and Askarova, Sholpan},
  title = {Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {10964},
  doi = {10.3390/ijms252010964}
}
Kostenlos starten →